NASDAQ •
Healthcare •
Diagnostics & Research •
Quote as of 07/02/2026 16:00
Company Profile
IndustryDiagnostics & Research
SectorHealthcare
ExchangeNASDAQ
Market Capitalization44.56 mln
Float1.41 mln
Earnings Date08/14/2026
Piotroski F-Score
5
/ 9
Neutral
Beneish M-Score
-1.91
Caution advised
Relative Strength
89
/ 100
Strongly outperforming
Debt / Equity
0.25
Very low leverage
ROE
-6.94
Negative
Dividend Yield
0.00%
No dividend
Business Description
Precipio is a Connecticut-based company specializing in cancer diagnostics, offering blood cancer testing services alongside its own line of laboratory tools and genetic testing panels. Its products help medical professionals identify cancer at the cellular and genetic level with greater accuracy. The company also partners with pharmaceutical and biotech firms to support research through biomarker testing and clinical project work.
